|1.||Miranda, Antonio: 7 articles (07/2013 - 09/2007)|
|2.||Daffre, Sirlei: 4 articles (01/2012 - 09/2007)|
|3.||Domingues, Tatiana M: 2 articles (07/2013 - 01/2013)|
|4.||Paredes-Gamero, Edgar J: 2 articles (01/2013 - 07/2012)|
|5.||Taborda, Carlos P: 2 articles (01/2012 - 09/2009)|
|6.||Rodrigues, Elaine G: 2 articles (09/2009 - 01/2008)|
|7.||Travassos, Luiz R: 2 articles (09/2009 - 01/2008)|
|8.||Nimrichter, Leonardo: 2 articles (01/2008 - 09/2007)|
|9.||Seelig, Joachim: 1 article (07/2013)|
|10.||Riske, Karin A: 1 article (07/2013)|
01/01/2012 - "Gomesin proved to be effective against experimental Candida albicans infection. "
01/01/2012 - "Gomesin's mechanism is not fully understood, but we hypothesise that the peptide acts through the permeabilisation of the yeast membrane leading to death and/or releasing the yeast antigens that trigger the host immune response against infection. "
03/18/2013 - "The current study demonstrates that cyclization improves the in vitro stability of gomesin over a 24 hour time period and enhances cytotoxicity against a cancer cell line without being toxic to a noncancerous cell line. "
01/01/2013 - "Gomesin (Gm) exhibits potent cytotoxic activity against cancer cells by a membrane pore formation induced after well-orchestrated intracellular mechanisms. "
01/01/2008 - "A direct cytotoxicity of gomesin in murine melanoma B16F10-Nex2 cells and several human tumor cell lineages was observed in vitro, with IC(50) values below 5 microM. "
01/01/2008 - "Topical treatment of subcutaneous murine melanoma with gomesin incorporated in a cream base significantly delayed tumor growth. "
01/01/2008 - "At doses causing partial growth of tumor cells, gomesin allowed internalization of macromolecules (immunoglobulins), which increased the cytotoxic effect. "
|2.||Tachypleus tridentatus tachyplesin peptide